迈克生物(300463.SZ):2名股东及实控人完成减持1211.72万股
格隆汇1月3日丨迈克生物(300463.SZ)公布,公司实际控制人之一郭雷计划自2019年11月28日至2020年02月26日(窗口期不减持),通过大宗交易方式减持不超过1115.11万股公司股份,即不超过公司当前总股本(扣除回购专用账户持有股份数量后)的2%;持股5%以上股东王传英计划自减持计划公告披露之日起15个交易日后的90个自然日内(窗口期不减持),通过集中竞价方式减持不超过557.55万股公司股份,即不超过公司当前总股本(扣除回购专用账户持有股份数量后)的1%,自减持计划公告披露之日起3个交易日后的90个自然日内(窗口期不减持),通过大宗交易方式减持不超过557.55万股公司股份,即不超过公司当前总股本(扣除回购专用账户持有股份数量后)的1%。
近日,公司收到公司实际控制人之一郭雷、原持股5%以上股东王传英出具的《关于减持公司股份计划完成的告知函》,截至本公告披露之日,郭雷、王传英本次减持计划已实施完毕,合计减持公司1211.72万股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.